{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:22:35Z","timestamp":1764174155187,"version":"3.44.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.ad.2015.04.014","type":"journal-article","created":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T03:24:53Z","timestamp":1435721093000},"page":"644-650","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Quality of Life and Side Effects in Patients with Actinic Keratosis Treated With Ingenol Mebutate: A Pilot Study"],"prefix":"10.1016","volume":"106","author":[{"given":"E.","family":"Jubert-Esteve","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.J.","family":"del Pozo-Hernando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Izquierdo-Herce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Bauz\u00e1-Alonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Mart\u00edn-Santiago","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Jones-Caballero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2015.04.014_bib0155","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1046\/j.1365-2133.2000.03541.x","article-title":"Prevalence of solar damage and actinic keratosis in a Merseyside population","volume":"142","author":"Memon","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2015.04.014_bib0160","first-page":"1099","article-title":"The kinetics of skin cancer: progression of actinic keratosis to squamous cell carcinoma","volume":"33","author":"Fuchs","year":"2007","journal-title":"Dermatol Surg Off Publ Am Soc Dermatol Surg Al"},{"key":"10.1016\/j.ad.2015.04.014_bib0165","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s00105-002-0358-4","article-title":"Skin diseases in organ transplant patients","volume":"53","author":"Ulrich","year":"2002","journal-title":"Hautarzt Z F\u00fcr Dermatol Venerol Verwandte Geb"},{"key":"10.1016\/j.ad.2015.04.014_bib0170","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2165\/00019053-200927060-00002","article-title":"Pharmacoeconomic considerations in treating actinic keratosis","volume":"27","author":"Neidecker","year":"2009","journal-title":"PharmacoEconomics"},{"key":"10.1016\/j.ad.2015.04.014_bib0175","first-page":"1462","article-title":"The paradigm shift in treating actinic keratosis: a comprehensive strategy","volume":"11","author":"Stockfleth","year":"2012","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.ad.2015.04.014_bib0180","first-page":"651","article-title":"Development of a treatment algorithm for actinic keratoses: a European consensus","volume":"18","author":"Stockfleth","year":"2008","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.ad.2015.04.014_bib0185","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ad.2013.11.013","article-title":"Spanish adaptation of the European guidelines for the evaluation and treatment of actinic keratosis","volume":"105","author":"Ferr\u00e1ndiz","year":"2014","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.ad.2015.04.014_bib0190","first-page":"241","article-title":"What is the role of field-directed therapy in the treatment of actinic keratosis? Part 1: overview and investigational topical agents","volume":"89","author":"Berman","year":"2012","journal-title":"Cutis"},{"key":"10.1016\/j.ad.2015.04.014_bib0195","first-page":"722","article-title":"Results of an investigator-initiated single-blind split-face comparison of photodynamic therapy and 5% imiquimod cream for the treatment of actinic keratoses","volume":"38","author":"Hadley","year":"2012","journal-title":"Dermatol Surg Off Publ Am Soc Dermatol Surg Al"},{"key":"10.1016\/j.ad.2015.04.014_bib0200","first-page":"35","article-title":"Non-adherence to topical treatments for actinic keratosis","volume":"8","author":"Shergill","year":"2013","journal-title":"Patient Prefer Adher"},{"key":"10.1016\/j.ad.2015.04.014_bib0205","first-page":"129","article-title":"Quality of life in health care of non-melanoma skin cancer \u2013 results of a pilot study","volume":"9","author":"Steinbauer","year":"2011","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.ad.2015.04.014_bib0210","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1159\/000349992","article-title":"Dermatology life quality index and side effects after topical photodynamic therapy of actinic keratosis","volume":"226","author":"Gholam","year":"2013","journal-title":"Dermatol Basel Switz"},{"key":"10.1016\/j.ad.2015.04.014_bib0215","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/bjd.12036","article-title":"Assessing the influence of actinic keratosis on patients\u2019 quality of life: the AKQoL questionnaire","volume":"168","author":"Esmann","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2015.04.014_bib0220","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1056\/NEJMoa1111170","article-title":"Ingenol mebutate gel for actinic keratosis","volume":"366","author":"Lebwohl","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ad.2015.04.014_bib0225","series-title":"70th annual meeting of the American Academy of Dermatology","article-title":"Two-day topical treatment with ingenol mebutate gel, 0.05% for actinic keratoses on the trunk and extremities: analysis of data pooled from two trials","author":"Anderson","year":"2012"},{"key":"10.1016\/j.ad.2015.04.014_bib0230","series-title":"XV World Congress on Cancers of the Skin","article-title":"Ingenol mebutate 0.015% gel repeat use for multiple actinic keratoses on face and scalp: FIELD Study REPEAT, a 12-month phase 3 clinical study","author":"Garbe","year":"2014"},{"key":"10.1016\/j.ad.2015.04.014_bib0235","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1046\/j.1365-4362.2000.00944.x","article-title":"The Spanish version of Skindex-29","volume":"39","author":"Jones-Caballero","year":"2000","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.ad.2015.04.014_bib0240","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/1523-1747.ep12365600","article-title":"Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness","volume":"107","author":"Chren","year":"1996","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ad.2015.04.014_bib0245","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/archderm.1997.03890470111018","article-title":"Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases","volume":"133","author":"Chren","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ad.2015.04.014_bib0250","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1477-7525-2-12","article-title":"Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease","volume":"2","author":"Atkinson","year":"2004","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.ad.2015.04.014_bib0255","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s13555-014-0059-9","article-title":"A New, Objective, Quantitative Scale for Measuring Local Skin Responses Following Topical Actinic Keratosis Therapy with Ingenol Mebutate","volume":"4","author":"Rosen","year":"2014","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.ad.2015.04.014_bib0260","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology Life Quality Index (DLQI) \u2013 a simple practical measure for routine clinical use","volume":"19","author":"Finlay","year":"1994","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.ad.2015.04.014_bib0265","series-title":"42nd European academy of dermatology and venereology congress","article-title":"Validaci\u00f3n de la versi\u00f3n espa\u00f1ola del actinic keratosis quality of life questionnaire-adaptaci\u00f3n al castellano y resultados preliminares","author":"Longo","year":"2014"},{"key":"10.1016\/j.ad.2015.04.014_bib0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/135916","article-title":"Treatment of subclinical actinic keratoses with topical imiquimod 5% cream: an observational study","volume":"2014","author":"Kopera","year":"2014","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.ad.2015.04.014_bib0275","first-page":"47","article-title":"Reduced degree of irritation during a second cycle of ingenol mebutate gel 0.015% for the treatment of actinic keratosis","volume":"95","author":"Jim On","year":"2015","journal-title":"Cutis"},{"key":"10.1016\/j.ad.2015.04.014_bib0280","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2310\/7750.2013.13143","article-title":"Measuring the severity of topical 5-fluorouracil toxicity","volume":"18","author":"Korgavkar","year":"2014","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.ad.2015.04.014_bib0285","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/jdv.12530","article-title":"Physician perceptions and experience of current treatment in actinic keratosis","volume":"29","author":"Stockfleth","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2015.04.014_bib0290","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jaad.2005.12.021","article-title":"Determining the relative importance of patient motivations for nonadherence to topical corticosteroid therapy in psoriasis","volume":"55","author":"Brown","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2015.04.014_bib0295","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3109\/09546634.2012.757285","article-title":"Patients\u2019 perceptions of topical treatments of actinic keratosis","volume":"25","author":"Esmann","year":"2014","journal-title":"J Dermatol Treat"},{"key":"10.1016\/j.ad.2015.04.014_bib0300","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/sj.jid.5700110","article-title":"Reliable methods to evaluate the burden of actinic keratoses","volume":"126","author":"Atkins","year":"2006","journal-title":"J Invest Dermatol"}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731015002653?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731015002653?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T01:04:04Z","timestamp":1757552644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731015002653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0001731015002653"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2015.04.014","relation":{},"ISSN":["0001-7310"],"issn-type":[{"type":"print","value":"0001-7310"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quality of Life and Side Effects in Patients with Actinic Keratosis Treated With Ingenol Mebutate: A Pilot Study","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2015.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Espa\u00f1a, S.L.U. and AEDV. All rights reserved.","name":"copyright","label":"Copyright"}]}}